News
RGC
30.80
-8.66%
-2.92
Regencell Bioscience falls -9.5%
TipRanks · 2d ago
Regencell Bioscience rises 23.9%
TipRanks · 4d ago
Regencell Bioscience Sets Up ATM Share Sales Program With Univest Securities
TipRanks · 6d ago
Regencell Bioscience Launches $500 Million At-the-Market Share Offering Program
TipRanks · 6d ago
Regencell Bioscience files sales agreement with Univest Securities for equity distribution program
Reuters · 6d ago
Regencell Bioscience files for up to USD 500 million at-the-market share offering
Reuters · 6d ago
Regencell Bioscience files to sell ordinary shares, no amount given
TipRanks · 6d ago
REGENCELL BIOSCIENCE HOLDINGS LTD FILES FOR COMMON STOCK SHELF; SIZE NOT DISCLOSED - SEC FILING
Reuters · 6d ago
Weekly Report: what happened at RGC last week (0323-0327)?
Weekly Report · 6d ago
Regencell Bioscience falls -8.7%
TipRanks · 03/23 16:06
Weekly Report: what happened at RGC last week (0316-0320)?
Weekly Report · 03/23 09:41
Regencell Bioscience rises 26.7%
TipRanks · 03/18 14:06
Regencell Bioscience Director William Wing Yan Lo Files Initial Beneficial Ownership Statement
Reuters · 03/18 13:18
Regencell Bioscience Holdings Ltd. Director Margaret Hoor Han Lo Files Initial Beneficial Ownership Statement
Reuters · 03/18 13:17
Regencell Bioscience files Form 3 initial beneficial ownership statement for Director Hui Evana Yee Wah
Reuters · 03/18 13:16
Regencell Bioscience Files Form 3 Initial Beneficial Ownership Statement for Financial Controller Chan Ho Yau
Reuters · 03/18 13:15
Regencell Bioscience Holdings files Form 3 for COO and Chief Strategy Officer James Wai Hong Chung
Reuters · 03/18 13:14
Regencell Bioscience Holdings Ltd. Chief Business Officer Au Yat-Pui files initial beneficial ownership statement
Reuters · 03/18 13:13
Regencell Bioscience Holdings Ltd. CEO Yat-Gai Au files initial beneficial ownership statement for 437.9 million shares
Reuters · 03/18 13:12
Weekly Report: what happened at RGC last week (0309-0313)?
Weekly Report · 03/16 09:40
More
Webull provides a variety of real-time RGC stock news. You can receive the latest news about Regencell Bioscience Holdings Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RGC
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.